Tonix Pharmaceuticals Holding Corp. (TNXP)
5.43
-0.35
(-6.06%)
USD |
NASDAQ |
Oct 21, 16:00
5.42
-0.01
(-0.18%)
After-Hours: 20:00
Tonix Pharmaceuticals Net Income (Annual) : -124.02M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -124.02M |
| December 31, 2024 | -130.04M |
| December 31, 2023 | -116.66M |
| December 31, 2022 | -110.22M |
| December 31, 2021 | -92.29M |
| December 31, 2020 | -50.46M |
| December 31, 2019 | -28.62M |
| December 31, 2018 | -26.09M |
| December 31, 2017 | -21.12M |
| December 31, 2016 | -38.84M |
| Date | Value |
|---|---|
| December 31, 2015 | -48.05M |
| December 31, 2014 | -27.62M |
| December 31, 2013 | -10.88M |
| December 31, 2012 | -9.450M |
| December 31, 2011 | -3.470M |
| December 31, 2010 | -1.964M |
| December 31, 2009 | -0.0309M |
| December 31, 2008 | -0.0211M |
| December 31, 2007 | -0.001M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | -84.95M |
| Nektar Therapeutics | -164.08M |
| Heron Therapeutics, Inc. | -20.20M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |